What happens when you democratize DNA? 23andMe started 12 years ago with the belief that when you break down barriers to genetic information, you enable revolutions in healthcare and research. With the largest genotyped, phenotyped, consented and recontactable database of individuals in the world, we can do research in unprecedented ways. Find out how we are leveraging these capabilities in scientific discovery, therapeutics, and consumer product development.
The audience for this webinar are those who believe consumers will power the future of genetic research.